Current status of PET in breast cancer imaging, staging, and therapy
- 1 July 2001
- journal article
- review article
- Published by Elsevier in Seminars in Roentgenology
- Vol. 36 (3) , 250-260
- https://doi.org/10.1053/sroe.2001.25126
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Overview of breast imagingSeminars in Roentgenology, 2001
- Metastases from Unknown Primary Tumor PET-FDG as Initial Diagnostic Procedure?Clinical Positron Imaging, 2000
- Positron Emission Mammographic Instrument: Initial ResultsRadiology, 2000
- Value of Combined FDG PET and MR Imaging in the Evaluation of Suspected Recurrent Local-Regional Breast Cancer: Preliminary ExperienceRadiology, 1999
- Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistryEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucoseJNCI Journal of the National Cancer Institute, 1996
- Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-GlucoseJournal of Computer Assisted Tomography, 1993
- Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancerCancer, 1993
- The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast DiseaseAnnals of Surgery, 1992
- POSITRON EMISSION TOMOGRAPHY FOR IN-VIVO MEASUREMENT OF REGIONAL BLOOD FLOW, OXYGEN UTILISATION, AND BLOOD VOLUME IN PATIENTS WITH BREAST CARCINOMAThe Lancet, 1984